Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

Item
http://www.wikidata.org/entity/Q33193741
The myeloma stem cell concept, revisited: from phenomenology to operational termsIdentification of ID-1 as a potential target gene of MMSET in multiple myelomaSerum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma.Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy.Toll-like receptors mediate proliferation and survival of multiple myeloma cells.Impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy.Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis.Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma.A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
P2860

Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

Item
http://www.wikidata.org/entity/Q33193741
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Occurrence of dysregulated onc ...... or different disease entities.
@ast
Occurrence of dysregulated onc ...... or different disease entities.
@en
type
label
Occurrence of dysregulated onc ...... or different disease entities.
@ast
Occurrence of dysregulated onc ...... or different disease entities.
@en
prefLabel
Occurrence of dysregulated onc ...... or different disease entities.
@ast
Occurrence of dysregulated onc ...... or different disease entities.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Occurrence of dysregulated onc ...... for different disease entities
@en
P2093
P304
P31
P356
10.1046/J.1365-2141.2003.04577.X
P407
P433
P478
P50
P577
P5875
P698